Global Health and Emerging Pathogens Institute | sciencenewsnet.in

Breaking News

Novel material supercharges innovation in electrostatic energy storage

A Common Pathway in the Brain That Enables Addictive Drugs to Hijack Natural Reward Processing Has Been Identified by Mount Sinai

MSU expert to attend oral arguments in SCOTUS case that could turn homelessness into a crime

New urine-based test detects high-grade prostate cancer, helping men avoid unnecessary biopsies

Dana-Farber Chief Scientific Officer, Kevin Haigis, PhD, elected as Fellow of the American Association for the Advancement of Science

Hubble Goes Hunting for Small Main Belt Asteroids

Two U Professors Selected as AAAS Fellows

New research finds electric vehicles depreciate faster than gas cars, but the trend is changing

Moffitt Researchers Discover New Therapeutic Target for Non-Small Cell Lung Cancer

UIowa finance expert says AI will only slowly affect hiring on Wall Street

19 Apr, 2024

First Stem Cells From a Bat Species Known to Harbor SARS-CoV-2 Could Shed Light on Virus Survival and Molecular Adaptability

February 21, 2023 sarah JonasResearch Results

Researchers from the Icahn School of Medicine at Mount Sinai have generated the first induced pluripotent stem cells (iPSCs) from bats, gaining valuable insights into the close relationship between bats and viruses.

Mount Sinai Researchers Awarded $16 Million to Develop Antivirals Against Viruses With Pandemic Potential

June 1, 2022 sarah JonasAnnouncement

Researchers at the Icahn School of Medicine at Mount Sinai have been awarded an initial $16 million from the National Institutes of Health (NIH) to discover and develop globally accessible and affordable novel oral antivirals to combat COVID-19 and future pandemics.